Literature DB >> 9029147

A protein-arginine methyltransferase binds to the intracytoplasmic domain of the IFNAR1 chain in the type I interferon receptor.

C Abramovich1, B Yakobson, J Chebath, M Revel.   

Abstract

The intracytoplasmic domain (IC) of cytokine receptors provides docking sites for proteins which mediate signal transduction. Thus, in interferon-alpha,beta receptors (IFNAR1 and 2), the IC region binds protein-tyrosine and -serine/threonine kinases which phosphorylate the receptor and the associated Stat transcription factors. A two-hybrid screening was carried out to identify additional proteins which could interact with the IC domain of the IFNAR1 chain of the IFN-alpha,beta receptor. Several positive clones representing a protein sequence designated IR1B4 were recovered from a human cDNA library. IR1B4 was identified as the human homolog of PRMT1, a protein-arginine methyltransferase from rat cells. Flag-IR1B4 fusion proteins bind to the isolated IFNAR1 intracytoplasmic domain produced in Escherichia coli, as well as to the intact IFNAR1 chain extracted by detergent from human U266 cell membranes. S-Adenosylmethionine-dependent methyltransferase activity was precipitated by anti-IFNAR1 antibodies from untreated human cells. IR1B4/PRMT1 is involved in IFN action since U266 cells rendered deficient in this methyltransferase by antisense oligonucleotides become more resistant to growth inhibition by IFN. Methylation of proteins by enzymes which can attach to the IC domains of receptors may be a signaling mechanism complementing protein phosphorylation. Among substrates methylated by PRMT1 are RNA-binding heterogeneous nuclear ribonucleoproteins (hnRNPs) which are involved in mRNA processing, splicing and transport into the cytoplasm.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9029147      PMCID: PMC1169633          DOI: 10.1093/emboj/16.2.260

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  34 in total

1.  Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase.

Authors:  O Colamonici; H Yan; P Domanski; R Handa; D Smalley; J Mullersman; M Witte; K Krishnan; J Krolewski
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

2.  Direct association of STAT3 with the IFNAR-1 chain of the human type I interferon receptor.

Authors:  C H Yang; W Shi; L Basu; A Murti; S N Constantinescu; L Blatt; E Croze; J E Mullersman; L M Pfeffer
Journal:  J Biol Chem       Date:  1996-04-05       Impact factor: 5.157

3.  In vivo and in vitro arginine methylation of RNA-binding proteins.

Authors:  Q Liu; G Dreyfuss
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

Review 4.  Histone deacetylase: a regulator of transcription.

Authors:  A P Wolffe
Journal:  Science       Date:  1996-04-19       Impact factor: 47.728

5.  Cloning and expression of a long form of the beta subunit of the interferon alpha beta receptor that is required for signaling.

Authors:  P Domanski; M Witte; M Kellum; M Rubinstein; R Hackett; P Pitha; O R Colamonici
Journal:  J Biol Chem       Date:  1995-09-15       Impact factor: 5.157

6.  Expression and signaling specificity of the IFNAR chain of the type I interferon receptor complex.

Authors:  S N Constantinescu; E Croze; A Murti; C Wang; L Basu; D Hollander; D Russell-Harde; M Betts; V Garcia-Martinez; J E Mullersman; L M Pfeffer
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

7.  Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1.

Authors:  M David; H E Chen; S Goelz; A C Larner; B G Neel
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

8.  Phosphorylated interferon-alpha receptor 1 subunit (IFNaR1) acts as a docking site for the latent form of the 113 kDa STAT2 protein.

Authors:  H Yan; K Krishnan; A C Greenlund; S Gupta; J T Lim; R D Schreiber; C W Schindler; J J Krolewski
Journal:  EMBO J       Date:  1996-03-01       Impact factor: 11.598

9.  Mutant U5A cells are complemented by an interferon-alpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster.

Authors:  G Lutfalla; S J Holland; E Cinato; D Monneron; J Reboul; N C Rogers; J M Smith; G R Stark; K Gardiner; K E Mogensen
Journal:  EMBO J       Date:  1995-10-16       Impact factor: 11.598

10.  Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN-alpha and IFN-beta.

Authors:  C Abramovich; L M Shulman; E Ratovitski; S Harroch; M Tovey; P Eid; M Revel
Journal:  EMBO J       Date:  1994-12-15       Impact factor: 11.598

View more
  38 in total

1.  Crystal structure of the conserved core of protein arginine methyltransferase PRMT3.

Authors:  X Zhang; L Zhou; X Cheng
Journal:  EMBO J       Date:  2000-07-17       Impact factor: 11.598

2.  Methylation of Xenopus CIRP2 regulates its arginine- and glycine-rich region-mediated nucleocytoplasmic distribution.

Authors:  Kazuma Aoki; Yasuhiro Ishii; Ken Matsumoto; Masafumi Tsujimoto
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

3.  Structure of the predominant protein arginine methyltransferase PRMT1 and analysis of its binding to substrate peptides.

Authors:  Xing Zhang; Xiaodong Cheng
Journal:  Structure       Date:  2003-05       Impact factor: 5.006

Review 4.  Chemical and biochemical approaches in the study of histone methylation and demethylation.

Authors:  Keqin Kathy Li; Cheng Luo; Dongxia Wang; Hualiang Jiang; Y George Zheng
Journal:  Med Res Rev       Date:  2012-07       Impact factor: 12.944

Review 5.  Small Molecule Inhibitors of Protein Arginine Methyltransferases.

Authors:  Hao Hu; Kun Qian; Meng-Chiao Ho; Y George Zheng
Journal:  Expert Opin Investig Drugs       Date:  2016-02-16       Impact factor: 6.206

Review 6.  Minireview: protein arginine methylation of nonhistone proteins in transcriptional regulation.

Authors:  Young-Ho Lee; Michael R Stallcup
Journal:  Mol Endocrinol       Date:  2009-01-22

7.  Protein arginine methyltransferase 5 regulates ERK1/2 signal transduction amplitude and cell fate through CRAF.

Authors:  Pedro Andreu-Pérez; Rosaura Esteve-Puig; Carlos de Torre-Minguela; Marta López-Fauqued; Joan Josep Bech-Serra; Stephan Tenbaum; Elena R García-Trevijano; Francesc Canals; Glenn Merlino; Matías A Avila; Juan A Recio
Journal:  Sci Signal       Date:  2011-09-13       Impact factor: 8.192

Review 8.  Transmethylation in immunity and autoimmunity.

Authors:  Brian R Lawson; Theodoros Eleftheriadis; Virginie Tardif; Rosana Gonzalez-Quintial; Roberto Baccala; Dwight H Kono; Argyrios N Theofilopoulos
Journal:  Clin Immunol       Date:  2011-12-24       Impact factor: 3.969

9.  Methyltransferase PRMT1 is a binding partner of HBx and a negative regulator of hepatitis B virus transcription.

Authors:  Shirine Benhenda; Aurélie Ducroux; Lise Rivière; Bijan Sobhian; Michael D Ward; Sarah Dion; Olivier Hantz; Ulrike Protzer; Marie-Louise Michel; Monsef Benkirane; Oliver J Semmes; Marie-Annick Buendia; Christine Neuveut
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

10.  An inhibitor of protein arginine methyltransferases, 7,7'-carbonylbis(azanediyl)bis(4-hydroxynaphthalene-2-sulfonic acid (AMI-1), is a potent scavenger of NADPH-oxidase-derived superoxide.

Authors:  Feng Chen; David J R Fulton
Journal:  Mol Pharmacol       Date:  2009-11-10       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.